News

In a world first, scientists at Duke-NUS Medical School, the National Heart Centre Singapore (NHCS) and colleagues in Germany have shown that regenerative therapy to restore impaired kidney function may soon be a possibility.

An open-air, living laboratory is helping researchers improve understanding of how mineral weathering – the breaking down or dissolving of rocks and minerals over time – feeds into Earth's intricate life-support system.

A vaccine against Sudan virus that was based on the licenced Ebola virus vaccine has been shown to protect monkeys in a preclinical trial.

Gold nanorod probes combined with an optical microscope can now be used to detect signs of a highly contagious and lethal virus that poses a major threat to the swine industry worldwide.

From the first months of the COVID-19 pandemic, observers noted that men are more susceptible to severe infections of the SARS-CoV-2 virus, with increased death rates. One scientist at the Hackensack Meridian Center for Discovery and Innovation (CDI) has new findings which may answer why.

In the early days of the coronavirus pandemic, before vaccines were developed, a Dutch team aimed to identify whether the tuberculosis vaccine could provide some protection against COVID-19 in the elderly.

New research from the Centre of Cancer Immunology has shown that changing how tightly an antibody binds to a target could improve treatments for cancer.

A novel circovirus – a small, highly resistant DNA virus – has been discovered and linked to hepatitis in a case study of a patient in Europe.

White-tailed deer ­– the most abundant large mammal in North America – are harboring SARS-CoV-2 variants that once widely circulated but are no longer found in humans.

New vaccine design principles that are based on adjusting the structural location of an adjuvant and the antigen on a nanoscale vaccine have been shown to greatly increase cancer vaccine performance.